| Jun 18 |
‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
|
| Jun 18 |
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
|
| Jun 18 |
Charles River and Captain T Cell sign vector production agreement
|
| Jun 17 |
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
|
| Jun 11 |
Charles River (CRL) Partners to Reduce Animal Research Usage
|
| Jun 11 |
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
|
| Jun 7 |
Mizuho starts Charles River Labs at neutral, cites near-term challenges
|
| Jun 6 |
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
|
| Jun 4 |
Is It Too Late To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
|
| Jun 4 |
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
|
